Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1153 of 1,261
  1. US 6747055

    Water-soluble drugs and methods for their production

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  2. US 6747105

    Bis-Schiff base ligand-containing mono-metallocene olefin polymerization catalyst, its preparation process and application

    East China University of Science and Technology Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  3. US 6747042

    N-heterocyclic derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  4. US 6747013

    Therapy for cellular accumulation in chronic inflammatory diseases

    The Regents of the University of California Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  5. US 6747034

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  6. US 6747043

    Alkoxy aryl &bgr;2 adrenergic receptor agonists

    Theravance, Inc. Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  7. US 6747003

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  8. US 6746672

    Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis

    Regents of the University of Minnesota Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  9. US 6746662

    pH sensitive MRI contrast agents

    The Board of Regents of the University of Texas System Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  10. US 6746869

    Electrospraying apparatus and method for coating particles

    Regents of the University of Minnesota Β· Granted Jun 8, 2004 Β· Expires Jun 3, 2024

    expired
  11. EP 1423413

    SELEKTIV P-SELECTIN BINDENDE PEPTIDISCHE VERBINDUNGEN

    YAMANOUCHI EUROP BV [NL] Β· Granted Jun 2, 2004 Β· Expires May 28, 2024

    expired
  12. US 6743936

    Composites made using functionalized nanoparticles

    The Board of Regents of the University of Texas System Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  13. US 6743607

    Production of complex carbohydrates

    The Regents of the University of California Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  14. US 6743577

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  15. US 6743797

    Methods for treating cardiac arrhythmia

    The United States of America Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  16. US 6743924

    Method for producing 1-substituted-1,2,3-triazole derivative

    Takeda Chemical Industries Ltd. Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  17. US 6743626

    Artificial salivary gland

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  18. US 6743791

    Heterocyclic inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated Β· Granted Jun 1, 2004 Β· Expires May 27, 2024

    expired
  19. US 6740638

    Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

    Neurocrine Biosciences, Inc. Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired
  20. US 6740634

    Sustained release compositions, process for producing the same and utilization thereof

    Takeda Chemical Industries Ltd. Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired
  21. US 6740656

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired
  22. US 6740320

    Recombinant P53 adenovirus methods and compositions

    The Board of Regents of the University of Texas System Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired
  23. US 6740493

    Bone precursor cells: compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired
  24. US 6740339

    Quickly disintegrating solid preparations

    Takeda Chemical Industries Ltd. Β· Granted May 25, 2004 Β· Expires May 20, 2024

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.